Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model

Stasia A. Anderson, John Glod, Ali S. Arbab, Martha Noel, Parwana Ashari, Howard A. Fine, Joseph A. Frank

Research output: Contribution to journalArticle

224 Citations (Scopus)

Abstract

Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic Iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-L- lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors.

Original languageEnglish (US)
Pages (from-to)420-425
Number of pages6
JournalBlood
Volume105
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Stem cells
Glioma
Tumors
Stem Cells
Imaging techniques
Bone
Magnetic Resonance Imaging
Neoplasms
Brain Neoplasms
Magnetic resonance imaging
Brain
Bearings (structural)
Endothelial Cells
Genes
Bone Marrow
Gene therapy
Histology
SCID Mice
Gadolinium
von Willebrand Factor

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. / Anderson, Stasia A.; Glod, John; Arbab, Ali S.; Noel, Martha; Ashari, Parwana; Fine, Howard A.; Frank, Joseph A.

In: Blood, Vol. 105, No. 1, 01.01.2005, p. 420-425.

Research output: Contribution to journalArticle

Anderson, Stasia A. ; Glod, John ; Arbab, Ali S. ; Noel, Martha ; Ashari, Parwana ; Fine, Howard A. ; Frank, Joseph A. / Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. In: Blood. 2005 ; Vol. 105, No. 1. pp. 420-425.
@article{08cb34d9942c46eba47dc62f7acace94,
title = "Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model",
abstract = "Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic Iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-L- lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors.",
author = "Anderson, {Stasia A.} and John Glod and Arbab, {Ali S.} and Martha Noel and Parwana Ashari and Fine, {Howard A.} and Frank, {Joseph A.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1182/blood-2004-06-2222",
language = "English (US)",
volume = "105",
pages = "420--425",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model

AU - Anderson, Stasia A.

AU - Glod, John

AU - Arbab, Ali S.

AU - Noel, Martha

AU - Ashari, Parwana

AU - Fine, Howard A.

AU - Frank, Joseph A.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic Iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-L- lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors.

AB - Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic Iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-L- lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors.

UR - http://www.scopus.com/inward/record.url?scp=11144247257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144247257&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-06-2222

DO - 10.1182/blood-2004-06-2222

M3 - Article

C2 - 15331444

AN - SCOPUS:11144247257

VL - 105

SP - 420

EP - 425

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -